AbCellera Biologics (ABCL) Enterprise Value (2020 - 2026)
AbCellera Biologics (ABCL) posted Enterprise Value of -$102.1 million for Q1 2026, up 33.52% on a QoQ basis from -$153.5 million in Q4 2025, and up 83.81% year-over-year from -$55.5 million in Q1 2025.
AbCellera Biologics (ABCL) Enterprise Value (2020 - 2026) Analysis & Trends
AbCellera Biologics' Enterprise Value history runs 7 years deep, the most recent figure standing at -$102.1 million for Q1 2026.
- Quarterly Enterprise Value rose 83.81% year-over-year to -$102.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$102.1 million (up 83.81% YoY) and the FY2025 annual result came in at -$153.5 million, down 183.23% from the prior year.
- Enterprise Value was -$102.1 million for Q1 2026 at AbCellera Biologics, up from -$153.5 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$30.8 million in Q4 2023 and bottomed at -$1.0 billion in Q2 2022.
- A 5-year average of -$434.3 million and a median of -$397.0 million in 2022 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2023 — Enterprise Value soared 96.62% — and 2025, when it slumped 243.36%.
- AbCellera Biologics' Enterprise Value stood at -$911.5 million in 2022, then surged by 96.62% to -$30.8 million in 2023, then tumbled by 75.97% to -$54.2 million in 2024, then slumped by 183.23% to -$153.5 million in 2025, then jumped by 33.52% to -$102.1 million in 2026.
- Business Quant data shows ABCL's Enterprise Value at -$102.1 million in Q1 2026, -$153.5 million in Q4 2025, and -$520.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | -61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.83 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -1.91 Bn |
| 10 | AbCellera Biologics | 1.62 Bn | 1.62 Bn | - | -102.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -102.06 Mn |
| Dec 31, 2025 | -153.51 Mn |
| Sep 30, 2025 | -520.67 Mn |
| Jun 30, 2025 | -578.08 Mn |
| Mar 31, 2025 | -630.27 Mn |
| Dec 31, 2024 | -54.20 Mn |
| Sep 30, 2024 | -151.64 Mn |
| Jun 30, 2024 | -173.31 Mn |
| Mar 31, 2024 | -723.02 Mn |
| Dec 31, 2023 | -30.80 Mn |
| Sep 30, 2023 | -172.42 Mn |
| Jun 30, 2023 | -179.75 Mn |
| Mar 31, 2023 | -796.50 Mn |
| Dec 31, 2022 | -911.49 Mn |
| Sep 30, 2022 | -396.97 Mn |
| Jun 30, 2022 | -1.02 Bn |
| Mar 31, 2022 | -786.05 Mn |
| Dec 31, 2021 | -747.98 Mn |
| Sep 30, 2021 | -517.69 Mn |
| Jun 30, 2021 | -792.57 Mn |